A New Apheresis Device for Antithrombotic Drug Removal during Off-Pump Coronary Artery Bypass Surgery

A New Apheresis Device for Antithrombotic Drug Removal during Off-Pump Coronary Artery Bypass Surgery

<i>Background and Objectives</i>: The hemoadsorption device CytoSorb<sup>®</sup> (CytoSorbents Inc., Princeton, NJ, USA) has been shown to efficiently remove ticagrelor from whole blood in vitro. A promising clinical experience was made with the integration of the hemoadsorpt...

Full description

Bibliographic Details
Main Authors: Helmut Mair, Norman Micka, Ferdinand Vogt, Dow Rosenzweig, Frank Vogel, Benedikt Baumer, Stephanie Ulrich, Peter Lamm
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Medicina
Subjects:
OPCAB
CytoSorb<sup>®</sup>
ticagrelor
DAPT
adsorption
PUR-01
Online Access:https://www.mdpi.com/1648-9144/58/10/1427

Internet

https://www.mdpi.com/1648-9144/58/10/1427

Similar Items